Q-omics provides the consensus-scored REREP1Y profile across patient tissues and cancer cell-line models. REREP1Y expression is associated with patient survival in 4 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, REREP1Y RNA expression shows 3,861 significant gene co-expression associations, with the highest sampling consensus in LUSC. Together, these results highlight BLCA, and LUSC as cancer lineages where REREP1Y shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.